Skip to main content
. 2017 Jan 23;14(2):152–162. doi: 10.1177/1479164116679081

Figure 1.

Figure 1.

Effects of Aleglitazar on cytotoxicity in human cardiomyocytes (HCM) and wild-type mice cardiomyocytes (mCM-WT).

The cells were incubated with different concentrations of Aleglitazar (0–40 µM) for 12, 24 or 48 h. *p < 0.05 versus 0.0 µM Ale group (n = 4 in each group).